We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAL icon
1376
TAL Education Group
TAL
$5.79B
$53K ﹤0.01%
1,117
-3,081
-73% -$132K
IBTX
1377
DELISTED
Independent Bank Group, Inc.
IBTX
$53K ﹤0.01%
978
EDU icon
1378
New Oriental
EDU
$8.08B
$52K ﹤0.01%
429
-627
-59% -$75K
FFTY icon
1379
CapForce IBD 50 ETF
FFTY
$80.2M
$52K ﹤0.01%
+1,500
New +$50.7K
JHX icon
1380
James Hardie Industries
JHX
$15.6B
$52K ﹤0.01%
2,675
-44
-2% -$816
MFA
1381
MFA Financial
MFA
$935M
$52K ﹤0.01%
1,744
-320
-16% -$9.77K
MPT
1382
Medical Properties Trust
MPT
$2.89B
$52K ﹤0.01%
+2,500
New +$50.6K
OFLX icon
1383
Omega Flex
OFLX
$306M
$52K ﹤0.01%
485
+375
+341% +$36.6K
SR icon
1384
Spire
SR
$4.88B
$52K ﹤0.01%
630
+225
+56% +$18.4K
THO icon
1385
Thor Industries
THO
$4.13B
$52K ﹤0.01%
700
VVV icon
1386
Valvoline
VVV
$5.13B
$52K ﹤0.01%
2,466
+1,834
+290% +$40.5K
NEE.PRK
1387
DELISTED
NextEra Energy Capital Holdings, Inc. Series K Junior Subordinated Debentures due June 1, 2076
NEE.PRK
$52K ﹤0.01%
2,000
CORE
1388
DELISTED
Core Mark Holding Co., Inc.
CORE
$52K ﹤0.01%
1,913
+139
+8% +$3.85K
AEE icon
1389
Ameren
AEE
$31.1B
$51K ﹤0.01%
673
-35,263
-98% -$2.68M
ORMP icon
1390
Oramed Pharmaceuticals
ORMP
$171M
$51K ﹤0.01%
10,000
-10,000
-50% -$37.5K
TS icon
1391
Tenaris
TS
$28.1B
$51K ﹤0.01%
2,260
+1,404
+164% +$30.2K
VOX icon
1392
Vanguard Communication Services ETF
VOX
$5.69B
$51K ﹤0.01%
548
+50
+10% +$4.52K
BFH icon
1393
Bread Financial
BFH
$4.36B
$50K ﹤0.01%
569
-93
-14% -$8.21K
GDXJ icon
1394
VanEck Junior Gold Miners ETF
GDXJ
$6.99B
$50K ﹤0.01%
1,200
-2,000
-63% -$76.3K
RDY icon
1395
Dr. Reddy's Laboratories
RDY
$9.77B
$50K ﹤0.01%
6,180
RSPD icon
1396
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$321M
$50K ﹤0.01%
1,350
SBS icon
1397
Sabesp
SBS
$19.4B
$50K ﹤0.01%
17,352
VOOG icon
1398
Vanguard S&P 500 Growth ETF
VOOG
$25.2B
$50K ﹤0.01%
1,722
WHR icon
1399
Whirlpool
WHR
$2.49B
$50K ﹤0.01%
342
TWLO icon
1400
Twilio
TWLO
$29.5B
$49K ﹤0.01%
509
-199
-28% -$20.3K

Similar funds

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.